Entresto 15 mg/16 mg, filmüberzogenes Granulat

7680692550026 CH-69255 Granulat
Entresto 15 mg/16 mg, filmüberzogenes Granulat
Entresto 15 mg/16 mg, filmüberzogenes Granulat
Entresto 15 mg/16 mg, filmüberzogenes Granulat
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Granulat
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/07/2025
Patient information leaflet
Français
25/07/2025
Patient information leaflet
Italien
25/07/2025

Detailed composition

Substance Quantity Type Category
GRAN
15.18 MG Substance Wirkstoff (Principe actif)
GRAN
16.07 MG Substance Wirkstoff (Principe actif)
GRAN
- Substance WIZUS
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance HNIDK
GRAN
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
GRAN
2.6 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69255
Drug name
Entresto, filmüberzogenes Granulat
Galenic form
GRFI
ATC Code
C09DX04
Authorization status
Z
Dispensing category
B
First authorization
21/08/2024
Authorization expiration date
20/08/2029
IT Number
02.07.2.
Domain
Human medicine
Field of application
Reduktion des Risikos der kardiovaskulären Mortalität und Morbidität bei systolischer Herzinsuffizienz

Package details

Description (FR)
ENTRESTO gran 15mg/16mg gélules à ouvr 60 pce
Description (DE)
ENTRESTO Gran 15mg/16mg Kaps zum Öffnen 60 Stk
Market launch
21/08/2024
Narcotic (BTM)
No

Other package sizes (1)

ENTRESTO gran 6mg/6mg gélules à ouvr 60 pce
60 KAP
GTIN: 7680692550019
View